BioMADE, the Bioindustrial Manufacturing Innovation Institute (MII), and the U.S. Department of Defense (DoD), announces an increase in its federal funds budget ceiling from an initial $87.5 million to over $500 million.
“BioMADE launched in 2021, and momentum for bioindustrial manufacturing has only increased,” said Dr. Douglas Friedman, BioMADE Chief Executive Officer. “This budget increase is representative of national interest in the power and promise that biomanufacturing holds for America’s future.”
Bioindustrial manufacturing can create new products and a domestic supply of current products by harnessing the power of biology. This capability strengthens the domestic supply chain, creates new opportunities for American farmers and rural communities, generates well-paying manufacturing job opportunities across the country, and expands manufacturing options to the defense industrial base.
“This budget increase and planned investment is a direct reflection of the Department’s strategy to accelerate technologies that will play critical roles in securing America’s advanced manufacturing capabilities. BioMADE’s ability to support the needs of the Nation’s nascent bioeconomy illustrates the value of the DoD’s nine MIIs and their public-private partnership model,” said Stephen Luckowski, the DoD MII Program Director.
“BioMADE’s research and development is already yielding significant progress in biomanufactured proteins, chemicals, fabrics, rubber, and more,” added Friedman. “Now is the time to capitalize on this momentum and keep moving forward with increased investments. The Department of Defense’s leadership in raising the contract ceiling will enable vastly expanded federal partnerships that will advance technology and build talent in the biomanufacturing ecosystem.”